Perinatal COVID-19 maternal and neonatal outcomes at two academic birth hospitals.
J Perinatol
; 42(10): 1338-1345, 2022 10.
Article
in English
| MEDLINE | ID: covidwho-2050310
ABSTRACT
OBJECTIVE:
Describe 1-month outcomes among newborns of persons with perinatal COVID-19. STUDYDESIGN:
Prospective observational study of pregnant persons who tested positive for SARS-CoV-2 between 14 days before and 3 days after delivery and their newborns, from 3/2020 to 3/2021 at two urban high-risk academic hospitals. Phone interviews were conducted to determine 1-month newborn outcomes.RESULTS:
Among 9748 pregnant persons, 209 (2.1%) tested positive for perinatal SARS-CoV-2. Symptomatically infected persons were more likely to have a preterm delivery due to worsening maternal condition and their newborns were more likely to test positive for SARS-CoV-2 compared with asymptomatic persons. Six of 191 (3.1%) infants tested were positive for SARS-CoV-2; none had attributable illness before discharge. Of 169 eligible families, 132 (78.1%) participated in post-discharge interviews; none reported their newborn tested positive for SARS-CoV-2 by 1 month of age.CONCLUSION:
Symptomatic perinatal COVID-19 had a substantial effect on maternal health but no apparent short-term effect on newborns.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pregnancy Complications, Infectious
/
Premature Birth
/
COVID-19
Type of study:
Cohort study
/
Diagnostic study
/
Experimental Studies
/
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Female
/
Humans
/
Infant
/
Infant, Newborn
/
Pregnancy
Language:
English
Journal:
J Perinatol
Journal subject:
Perinatology
Year:
2022
Document Type:
Article
Affiliation country:
S41372-022-01446-x
Similar
MEDLINE
...
LILACS
LIS